National Australia Bank Ltd. shares lift on Clydesdale Bank update

Shares of National Australia Bank Ltd. (ASX:NAB) are trading firmly higher following an ASX update on Clydesdale Yorkshire Banking Group (CYBG) this morning.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of National Australia Bank Ltd. (ASX: NAB) are trading firmly higher following an ASX update this morning.

In an announcement to the ASX, NAB said the proposed demerger of its UK subsidiary, the Clydesdale Yorkshire Banking Group (CYBG) is proceeding. It said the performance of CYBG in the three months to 31 December 2015 was in-line with expectations, noting a 6.6% growth in the bank's loan book and "strong" asset quality.

CYBG has long been a lagger for the NAB Banking Group and is often blamed for the bank's relatively poor share price performance. Indeed, many NAB executive management teams have come and gone trying to rid the bank of its poorly performing assets.

Under the control of CEO Andrew Thorburn, however, NAB has divested its US bank, sold most of its insurance business to Japan's Nippon Life, and is now pushing ahead with the divestment of CYBG in 2016.

It's NAB's intention to divest 75% of CYBG to current shareholders, listing the new shares on the ASX, with the remaining 25% going to new institutional owners on the London Stock Exchange.

Foolish takeaway

NAB shares have long underperformed their peers, largely thanks to its poorly performing non-core banking assets in the UK and, to a lesser extent, the USA. While CEO Andrew Thorburn has done a great job thus far reducing the bank's exposure to these assets, I think there are superior alternatives in the ASX financial sector to consider buying first.

Motley Fool writer/analyst Owen Raszkiewicz has no position in any stocks mentioned. Owen welcomes your feedback on Google plus (see below), LinkedIn or you can follow him on Twitter @ASXinvest. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »